Vascular dementia is diagnosed through a combination of cognitive testing, brain imaging, blood work, and neurological examination. No single test confirms it. Instead, doctors piece together evidence that cognitive decline is present, that cerebrovascular disease exists, and that the two are connected. That connection is the core diagnostic challenge, and it’s why the process typically involves multiple steps and sometimes multiple specialists.
What Doctors Are Looking For
The fundamental question in diagnosing vascular dementia isn’t just “is there cognitive decline?” It’s whether that decline was caused by problems with blood flow to the brain. Clinical guidelines rely on two main types of evidence to make that link: either a clear timing relationship between a stroke and the onset of cognitive problems, or a significant burden of blood vessel damage visible on brain imaging.
This is different from diagnosing Alzheimer’s disease, where the decline is gradual and steady. Vascular dementia often follows a “stepwise” pattern, where cognitive function drops noticeably after a vascular event and then plateaus for a while before dropping again. Some people, though, experience a slower, more progressive decline caused by chronic damage to the brain’s small blood vessels, which can look more like Alzheimer’s on the surface. That overlap is one reason the diagnostic workup is so thorough.
Cognitive Testing
Screening for cognitive problems usually starts in a primary care office with a standardized test. The Mini-Mental State Examination (MMSE) has been widely used for decades, but it has low sensitivity for vascular cognitive impairment. That’s because vascular damage tends to hit executive functions and processing speed hardest, and the MMSE doesn’t test those areas well. Executive function includes things like planning, organizing tasks, switching between activities, and solving problems.
The Montreal Cognitive Assessment (MoCA) is now the preferred screening tool for people with suspected vascular cognitive problems. It specifically includes subtests for executive function and psychomotor speed. The National Institute of Neurological Disorders and Stroke has endorsed its use as part of its recommended assessment standards. The MoCA takes about 10 to 15 minutes and covers attention, memory, language, visual-spatial ability, and abstract thinking.
If screening suggests a problem, you may be referred for more detailed neuropsychological testing. This involves a longer battery of tests administered by a neuropsychologist, and it can map out exactly which cognitive domains are affected and how severely. That pattern of deficits helps distinguish vascular dementia from other types.
Brain Imaging
MRI is the most important diagnostic tool for vascular dementia. The widely used NINDS-AIREN criteria state that a diagnosis of “probable” vascular dementia cannot be made without some form of brain imaging. An MRI reveals the specific types of blood vessel damage in the brain that point toward a vascular cause.
There are several key findings radiologists look for:
- White matter hyperintensities: Bright spots on MRI scans that indicate damage to the brain’s white matter, the wiring that connects different brain regions. These are caused by chronic reduced blood flow through small vessels.
- Lacunar infarcts: Small areas of dead tissue, between 3 and 15 millimeters, caused by blockages in tiny arteries deep in the brain. They appear as small cavities on the scan.
- Cerebral microbleeds: Tiny spots of old bleeding visible on specialized MRI sequences, indicating fragile small blood vessels.
- Brain atrophy: Overall shrinkage of brain tissue, measured as the ratio of brain volume to total skull volume.
For a diagnosis of probable vascular dementia, the imaging needs to show enough damage in the right locations. The criteria distinguish between large-vessel disease (bigger strokes in critical brain areas) and small-vessel disease (widespread white matter damage or multiple lacunar infarcts). For large-vessel disease, the damage must meet thresholds for both location and severity. For small-vessel disease involving white matter lesions, the same dual requirement applies. Multiple lacunar infarcts or damage to both sides of the thalamus, a deep brain structure involved in memory and attention, can meet the criteria on location alone.
Neurological Examination
A neurological exam looks for physical signs that blood vessel damage has affected the brain. This is a hands-on assessment where a doctor checks your reflexes, muscle strength, sensation, balance, vision, speech, and swallowing. Vascular dementia often leaves physical traces that other types of dementia do not.
Specific signs clinicians check for include weakness on one side of the body, facial drooping, abnormal reflexes (particularly the Babinski sign, where the big toe extends upward when the sole of the foot is stroked), slurred speech, difficulty swallowing, and visual field loss on one side. Gait problems are common and can take several forms: a one-sided limp from a prior stroke, a wide-based unsteady walk suggesting damage to the brain’s coordination centers, or a shuffling gait with small steps that resembles Parkinson’s disease. Primitive reflexes like the palmomental reflex (where stroking the palm causes the chin to twitch) and the snout reflex (where tapping near the mouth causes the lips to pucker) suggest damage to connections between the brain’s frontal lobes and deeper structures.
Physical symptoms also include unsteady balance and new or worsening problems with bladder control, which can appear earlier in vascular dementia than in Alzheimer’s disease.
Blood Tests and Lab Work
Blood tests don’t diagnose vascular dementia directly, but they serve two purposes: ruling out other treatable causes of cognitive decline and identifying the cardiovascular risk factors that drive vascular brain damage.
Standard lab work includes vitamin B12 levels (deficiency can cause reversible cognitive problems), thyroid function tests, blood glucose, kidney and liver function panels, and a complete blood count. Depending on the situation, doctors may also test for infections known to cause dementia, such as HIV and syphilis, or run a toxicology screen. In some cases, a lumbar puncture is performed to analyze spinal fluid for proteins associated with Alzheimer’s disease, which helps clarify whether vascular disease is the primary culprit or a contributing factor alongside Alzheimer’s pathology.
Cardiovascular risk assessment typically includes cholesterol levels, blood pressure readings, and blood sugar testing. These don’t diagnose vascular dementia, but they help explain what’s causing the blood vessel damage and guide treatment decisions.
The Hachinski Ischemic Score
The Hachinski Ischemic Score is a clinical tool designed to help differentiate vascular dementia from Alzheimer’s disease. It assigns points based on features like abrupt onset, stepwise deterioration, history of stroke, focal neurological symptoms, and emotional instability. A score of 7 or higher points toward vascular dementia. A score of 4 or lower suggests Alzheimer’s. Scores between 5 and 6 fall into an uncertain zone where mixed pathology is likely.
A meta-analysis of studies that verified diagnoses against autopsy findings showed the original cutoff scores performed well, with 89% sensitivity and 89% specificity. The score remains useful as a quick clinical tool, though it’s not a standalone diagnostic test and is typically used alongside imaging and cognitive assessment.
Levels of Diagnostic Certainty
Because vascular dementia is difficult to confirm with absolute certainty during life, diagnostic systems use tiered categories. The NINDS-AIREN criteria, one of the most widely used frameworks, classify diagnoses as possible, probable, or definite.
“Probable” vascular dementia requires documented cognitive decline, evidence of cerebrovascular disease on brain imaging, and a plausible relationship between the two (either the dementia began within three months of a recognized stroke, or there’s an abrupt or stepwise pattern of decline). “Possible” vascular dementia applies when the criteria are partially met, such as when imaging isn’t available or the timing relationship is unclear. “Definite” vascular dementia can only be confirmed through autopsy or brain biopsy, where both dementia and vascular brain damage are verified under a microscope with no other explanation for the cognitive decline.
The formal psychiatric classification system uses similar language, categorizing cases as “probably due to” or “possibly due to” vascular disease. The uncertainty isn’t about whether vascular disease is present. It’s about whether the vascular disease is actually what caused the cognitive problems, since many older adults have some degree of cerebrovascular disease without developing dementia.
Who Conducts the Evaluation
The diagnostic process often starts with a primary care doctor who notices cognitive changes or responds to concerns raised by a patient or family member. From there, referral to a neurologist is common. Neurologists have the expertise to interpret brain imaging, perform detailed neurological examinations, and distinguish vascular dementia from other conditions like Alzheimer’s disease, Lewy body dementia, or frontotemporal dementia.
Geriatricians, who specialize in the health of older adults, also play a role, particularly when multiple medical conditions coexist. Neuropsychologists handle the detailed cognitive testing that maps out which mental abilities are affected. In many cases, the diagnosis is a team effort. The process from initial concern to a clear diagnosis can take weeks to months, depending on how quickly imaging and specialist appointments can be scheduled and how clearly the clinical picture comes together.